Comorbidity, Hospitalization, and Medication Use and Their Influence on Mental and Motor Development of Young Infants With Down Syndrome
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE. Young infants with Down syndrome have an increased occurrence of several well-known medical conditions such as congenital heart and gastrointestinal disease. The aim of this study was to establish consequences like hospitalization and medication use rates and to determine their possible influence on early neurodevelopment. PATIENTS AND METHODS. This study compared 2 years of thyroxine treatment with placebo in 196 neonates with Down syndrome who were included in a previously reported randomized clinical trial. Parents were interviewed about comorbidity, hospitalization, and medication use at random assignment and regularly thereafter. Data were cross-checked with discharge letters when available. The influence of comorbidity on neurodevelopment at 2 years old (Bayley Scales of Infant Development II) was determined by stepwise multiple linear-regression analysis. RESULTS. Before trial entry, 163 infants with Down syndrome had been admitted to hospital for an average of 14.01 days, whereas during the trial, 95 of 181 infants who completed the trial were hospitalized for an average 19.75 days. Main hospitalization reasons during the trial were lung/airway and congenital heart and gastrointestinal disease. The 48 infants operated on for heart or gastrointestinal disease accounted for 1401 of the total number of 1876 hospital admission days during the trial and for 33 of 62 admissions for lung/airway infection. During their second year of life, ∼60% of the infants were prescribed drugs, mostly antibiotics and pulmonary. Regression analysis showed infantile spasms, “other” central nervous system disease, and gastrointestinal disease necessitating surgery to be associated with greater developmental age delays at 24 months old (mental: 6.87, 3.52, and 1.69 months; and motor: 3.59, 2.54, and 1.68 months, respectively). CONCLUSIONS. Hospital admission and medication use rates in young infants with Down syndrome are still very high, mainly because of congenital heart and gastrointestinal disease and acquired respiratory disease. Central nervous system disease and gastrointestinal disease necessitating surgery were independently associated with a worse developmental outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because many neonates with Down's syndrome have nonthyroidal illness due to (surgery for) cardiac or intestinal disease (44), TSH generation may be impaired resulting in a false-negative neonatal screening result (in TSH-based screening programs).”
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Roizen, N. J., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,331
Chromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703
Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease
Wakamatsu, N., Yamada, Y., Yamada, K., Ono, T., Nomura, N., Taniguchi, H., Kitoh, H., Mutoh, N., Yamanaka, T., Mushiake, K., et al. (2001) · Nature Genetics · doi:10.1038/86860 · Cited by 335
Infantile Epileptic Encephalopathy with Hypsarrhythmia (Infantile Spasms/West Syndrome)
Hrachovy, R. A., & Frost, J. D. (2003) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200311000-00004 · Cited by 183
Brooks, A. S., Bertoli‐Avella, A. M., Burzynski, G. M., Breedveld, G. J., Osinga, J., Boven, L. G., Hurst, J. A., Mancini, G. M. S., Lequin, M. H., de Coo, I. F. M., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431244 · Cited by 152
Seizure frequency and characteristics in children with Down syndrome
Goldberg‐Stern, H., Strawsburg, R. H., Patterson, B. J., Hickey, F. J., Bare, M. A., Gadoth, N., & deGrauw, T. J. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00239-x · Cited by 131
van Trotsenburg, A. S. P., Vulsma, T., van Rozenburg-Marres, S. L. R., van Baar, A. L., Ridder, J. C. D., Heymans, H. S. A., Tijssen, J. G. P., & de Vijlder, J. J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0130 · Cited by 130
Self-citation
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Because many neonates with Down’s syndrome have nonthyroidal illness due to (surgery for) cardiac or intestinal disease (44), TSH generation may be impaired resulting in a falsenegative neonatal screening result (in TSH-based screening programs).”
BackgroundInfections and immunodeficiency in Down syndrome
Ram, G., & Chinen, J. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04335.x · Cited by 465
Prevalence, Neonatal Characteristics, and First-Year Mortality of Down Syndrome: A National Study
Weijerman, M. E., van Furth, A. M., Vonk Noordegraaf, A., van Wouwe, J. P., Broers, C. J. M., & Gemke, R. J. B. J. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.09.045 · Cited by 238
Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
Wilcock, D. M., & Griffin, W. S. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-84 · Cited by 230
van Gameren-Oosterom, H. B. M., Fekkes, M., Buitendijk, S. E., Mohangoo, A. D., Bruil, J., & Van Wouwe, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021879 · Cited by 162
“A study among Dutch children showed that 24% of the children with DS were hospitalized twice or more for pulmonary infection or use inhalation medication for more than six months [35].”
Background
Metadata
- Authors
- van Trotsenburg, A. S. P., Heymans, H. S. A., Tijssen, J. G. P., de Vijlder, J. J. M., & Vulsma, T.
- Affiliations
- Departments of Pediatric Endocrinology
- Pediatrics
- Amsterdam UMC Location University of Amsterdam (NL)
- ORCID
- Tijssen, Jan G.P.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-10-01
- Volume
- 118
- Issue
- 4
- Pages
- 1633-1639
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2145802105
- Cited by
- 80
- References
- 12
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 7 · 2013: 6 · 2012: 4
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
- Health Sciences › Medicine › Surgery › Craniofacial Disorders and Treatments
- Keywords
- Down syndrome, comorbidities, hospitalization, medication use, infantile spasms, brain development, cognitive development, motor development, congenital heart disease, gastrointestinal diseases, respiratory infections, thyroxine therapy, developmental delay
- MeSH terms
- Child Development, Child, Preschool, Congenital Hypothyroidism, Double-Blind Method, Down Syndrome, Female, Follow-Up Studies, Gastrointestinal Diseases, Heart Defects, Congenital, Hospitalization, Humans, Infant, Male, Motor Skills, Nervous System, Thyroxine, Comorbidity, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comorbidity, Hospitalization, and Medication Use and Their Influence on Mental and Motor Development of Young Infants With Down Syndrome. https://app.cochat.ai/papers/10.1542/peds.2006-1136
- The paper
- van Trotsenburg, A. S. P., Heymans, H. S. A., Tijssen, J. G. P., de Vijlder, J. J. M., & Vulsma, T. (2006). Comorbidity, Hospitalization, and Medication Use and Their Influence on Mental and Motor Development of Young Infants With Down Syndrome. Pediatrics. https://doi.org/10.1542/peds.2006-1136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.